Ultragenyx Pharmaceutical Inc. (RARE) — key valuation metrics and fundamentals.
See the full interactive analysis →
Fair value compares RARE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.